REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/13/2026
Back to search
Official data from USPTO
ACELRX PHARMACEUTICALS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/14/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
01/15/2016
Registration date
11/22/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2023
Last transaction
03/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/19/2016
First use in commerce
09/19/2016
Drawing code
5
Owner type
03
Owner location
Redwood City, CA, US
Examiner
REGAN, JOHN B
Law office
M40
Current location
TMO LAW OFFICE 113
Mark description
The mark consists of the trademark "AcelRx Pharmaceuticals, Inc." in which the term "AcelRx" in blue and gray is above the terms "Phamaceuticals, Inc." in gray. "AcelRx" features a capital letter "A" and lower case letters "cel" all in blue to the left of the capital letter "R" in gray followed by a stylized letter "x". The left crossbars of the letter "x" are elongated and in blue and the right crossbars of the letter "x" are smaller and in gray.
Holders and representatives
Holders
AcelRx Pharmaceuticals, Inc.
Representatives
Brendan J. Hughes COOLEY LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for treating pain; pharmaceutical preparations for treating anxiety
Class 10
Drug delivery systems; medical devicea mechanical and electronic device used to administer medicationsperform timed medication deliveryto provide secure access to and delivery of medications
Publications
History of USPTO decisions and trademark events.
31 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/05/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/02/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/01/2023
E815
TEAS SECTION 8 & 15 RECEIVED
11/22/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/22/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/22/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/20/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/19/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/11/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/05/2016
IUAF
USE AMENDMENT FILED
09/19/2016
EISU
TEAS STATEMENT OF USE RECEIVED
09/19/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/09/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/14/2016
PUBO
PUBLISHED FOR OPPOSITION
06/14/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/25/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/06/2016
ALIE
ASSIGNED TO LIE
04/26/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/11/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
04/11/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/11/2016
DOCK
ASSIGNED TO EXAMINER
04/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2016
NWAP
NEW APPLICATION ENTERED
01/19/2016
Continuous trademark protection
Get notified about every new filing that threatens ACELRX PHARMACEUTICALS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.